Etiology Dependent Differences in Immunotherapy Response and Prognosis Between MASH-HCC and HBV-HCC
Journal of Hepatocellular Carcinoma · 2026-10 · Volume 13 · 1-14
DOI: 10.2147/jhc.s620276 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hepatocellular Carcinoma, 2026-10. Verfasst von Feixiang Xiong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People's Republic of China.
- National Center for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People's Republic of China.
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People's Republic of China.
- Beijing Institute of Infectious Diseases, Beijing, 100015, People's Republic of China.
- Beijing Key Laboratory of Viral Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People's Republic of China.
ORCID-Profile: Xuejie Zhang
Zitieren
APA
Xiong, F., Zhang, X., Chen, D., Zhou, Y., Meng, P., Yan, F., & Hou, Y. (2026). Etiology Dependent Differences in Immunotherapy Response and Prognosis Between MASH-HCC and HBV-HCC. Journal of Hepatocellular Carcinoma, Volume 13, 1-14. https://doi.org/10.2147/jhc.s620276
Vancouver
Xiong F, Zhang X, Chen D, Zhou Y, Meng P, Yan F, et al. Etiology Dependent Differences in Immunotherapy Response and Prognosis Between MASH-HCC and HBV-HCC. Journal of Hepatocellular Carcinoma. 2026;Volume 13:1-14. doi:10.2147/jhc.s620276
BibTeX
@article{Xiong2026,
author = {Xiong, Feixiang and Zhang, Xuejie and Chen, Dandan and Zhou, Yang and Meng, Peipei and Yan, Fengna and Hou, Yixin},
title = {Etiology Dependent Differences in Immunotherapy Response and Prognosis Between MASH-HCC and HBV-HCC},
journal = {Journal of Hepatocellular Carcinoma},
year = {2026},
volume = {Volume 13},
pages = {1--14},
doi = {10.2147/jhc.s620276}
}
EUVIMED